Profile data is unavailable for this security.
About the company
Jiangsu Recbio Technology Co Ltd is a China-based company mainly engaged in the research and development of vaccines. The Company has a portfolio of clinical-stage and pre-clinical stage vaccines, and its human papilloma virus (HPV) vaccine pipelines comprise of recombinant HPV 9-valent vaccine REC603, recombinant HPV 9-valent vaccines REC601 and REC602, recombinant HPV quadrivalent vaccine REC604a, and recombinant HPV 9-valent vaccine REC604b. The Company also involves in the development of Covid-19 vaccines. The Company mainly distributes products within domestic market.
- Revenue in HKD (TTM)0.00
- Net income in HKD-596.89m
- Incorporated2012
- Employees507.00
- LocationJiangsu Recbio Technology Co LtdNo. 888 Yaocheng AvenueChina Medical CityTAIZHOU ChinaCHN
- Phone+86 52 386818860
- Websitehttps://www.recbio.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VIVA Biotech Holdings | 2.17bn | -346.03k | 1.99bn | 2.04k | -- | 0.4832 | 7.87 | 0.9185 | -0.0055 | -0.0055 | 1.06 | 1.92 | 0.2603 | 5.26 | 5.18 | 1,045,291.00 | 0.4017 | -1.39 | 0.5601 | -1.68 | 33.66 | 34.81 | 1.54 | -5.44 | 1.46 | 3.19 | 0.2884 | -- | -9.42 | 59.31 | 78.03 | -- | 31.98 | -- |
| Golden Throat Holdings Group Co Ltd | 1.09bn | 285.32m | 2.30bn | 860.00 | 8.06 | 1.65 | 7.02 | 2.10 | 0.3859 | 0.3859 | 1.48 | 1.89 | 0.4994 | 3.23 | 4.07 | 1,259,993.00 | 13.01 | 11.00 | 19.26 | 15.63 | 72.29 | 72.79 | 26.06 | 24.67 | 1.93 | 37.74 | 0.2814 | 83.15 | -3.09 | 6.73 | -11.04 | 19.61 | -32.13 | 38.94 |
| Cutia Therapeutics | 216.38m | -570.56m | 3.12bn | 360.00 | -- | 2.31 | -- | 14.41 | -1.88 | -1.88 | 0.7109 | 4.24 | 0.1206 | 2.31 | 6.93 | 726,112.00 | -31.81 | -- | -35.82 | -- | 50.33 | -- | -263.68 | -- | 4.82 | -- | 0.1818 | -- | 1,110.83 | -- | -253.30 | -- | -- | -- |
| Jiangsu Recbio Technology Co Ltd | 0.00 | -596.89m | 3.93bn | 507.00 | -- | 4.28 | -- | -- | -1.25 | -1.25 | 0.00 | 1.90 | 0.00 | -- | -- | 0.00 | -25.33 | -- | -32.84 | -- | -- | -- | -- | -- | 0.9619 | -- | 0.4548 | -- | -- | -- | 20.86 | -- | -- | -- |
| Beijing Luzhu Biotechnology Co Ltd | 0.00 | -304.61m | 4.34bn | 148.00 | -- | 4.26 | -- | -- | -1.50 | -1.50 | 0.00 | 5.07 | 0.00 | -- | -- | 0.00 | -23.80 | -- | -25.44 | -- | -- | -- | -- | -- | 5.91 | -- | 0.0296 | -- | -- | -- | 65.62 | -- | -- | -- |
| Ocumension Therapeutics | 337.64m | -351.17m | 4.47bn | 477.00 | -- | 1.26 | -- | 13.23 | -0.5358 | -0.5358 | 0.515 | 4.34 | 0.103 | 2.40 | 2.48 | 760,455.40 | -10.71 | -38.78 | -11.55 | -41.47 | 58.29 | 62.30 | -104.01 | -975.82 | 5.00 | -- | 0.0055 | -- | 54.99 | -- | 5.68 | -- | 319.66 | -- |
| Shandong Boan Biotechnology Co Ltd | 783.28m | 67.26m | 4.87bn | 777.00 | 68.83 | 3.06 | 34.14 | 6.22 | 0.1321 | 0.1321 | 1.54 | 2.97 | 0.3069 | 1.10 | 2.60 | 963,447.80 | 2.63 | -- | 3.43 | -- | 74.10 | -- | 8.59 | -- | 1.03 | 4.01 | 0.3369 | -- | 19.80 | -- | 64.02 | -- | -- | -- |
Data as of Nov 08 2024. Currency figures normalised to Jiangsu Recbio Technology Co Ltd's reporting currency: Hong Kong Dollar HKD
3.57%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Lake Bleu Capital (Hong Kong) Ltd.as of 20 Feb 2023 | 11.30m | 3.57% |
Data from 05 Jun 2024 - 05 Jun 2024Source: FactSet Research Systems Inc.
